These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6638998)

  • 1. Minimal inhibitory concentrations of various antimicrobial agents for human oral anaerobic bacteria.
    Baker PJ; Slots J; Genco RJ; Evans RT
    Antimicrob Agents Chemother; 1983 Sep; 24(3):420-4. PubMed ID: 6638998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic susceptibility of black-pigmented Bacteroides isolates from the human oral cavity.
    Laatsch LJ; Hohenfeldt PR; Kos WL
    Antimicrob Agents Chemother; 1982 Oct; 22(4):698-700. PubMed ID: 7181479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic susceptibility of anaerobic bacteria from the human oral cavity.
    Baker PJ; Evans RT; Slots J; Genco RJ
    J Dent Res; 1985 Oct; 64(10):1233-44. PubMed ID: 3861655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of spiral gradient and conventional agar dilution for susceptibility testing of anaerobic bacteria.
    Wexler HM; Molitoris E; Jashnian F; Finegold SM
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1196-202. PubMed ID: 1929262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibilities of anaerobic bacteria: recent clinical isolates.
    Staneck JL; Washington JA
    Antimicrob Agents Chemother; 1974 Sep; 6(3):311-5. PubMed ID: 15830478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified agar dilution method for rapid antibiotic susceptibility testing of anaerobic bacteria.
    Hanson CW; Martin WJ
    Antimicrob Agents Chemother; 1978 Mar; 13(3):383-8. PubMed ID: 400819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of susceptibilities of anaerobic bacteria determined by agar dilution and by a microbroth method.
    Baron EJ; Bruckner DA
    Rev Infect Dis; 1984; 6 Suppl 1():S249-53. PubMed ID: 6718938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of anaerobic bacteria to antimicrobial agents.
    Collignon PJ; Munro R; Morris G
    Pathology; 1988 Jan; 20(1):48-52. PubMed ID: 3374973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility of anaerobic bacteria in Auckland 1987-90.
    Henderson G; Garner J; Morris A
    N Z Med J; 1992 Jan; 105(926):11-2. PubMed ID: 1549266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of anaerobic bacteria to ALP 201.
    Nord CE; Lindmark A; Persson I
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2137-9. PubMed ID: 2619278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of anaerobic bacteria in Auckland: 1991-1996.
    Shore KP; Pottumarthy S; Morris AJ
    N Z Med J; 1999 Nov; 112(1099):424-6. PubMed ID: 10678225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organisms isolated from dogs and cats with anaerobic infections and susceptibility to selected antimicrobial agents.
    Jang SS; Breher JE; Dabaco LA; Hirsh DC
    J Am Vet Med Assoc; 1997 Jun; 210(11):1610-4. PubMed ID: 9170087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of the E-test in evaluating the antimicrobial susceptibility of anaerobic bacteria of veterinary interest.
    Píriz S; Valle J; Hurtado MA; Mateos EM; Martin-Palomino P; Vadillo S
    Lett Appl Microbiol; 1995 Jun; 20(6):345-8. PubMed ID: 7786499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicentre study on antibiotic susceptibilities of anaerobic bacteria to cefoperazone-sulbactam and other antimicrobial agents.
    Clark RB; Bartelt MA; Chan EL; Dalton HP
    J Antimicrob Chemother; 1992 Jan; 29(1):57-67. PubMed ID: 1737725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of Sch 34343 and cefbuperazone against anaerobic bacteria.
    Shafran SD; Wong J; Chow AW
    Antimicrob Agents Chemother; 1985 May; 27(5):749-52. PubMed ID: 4015069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial Susceptibility Patterns of Anaerobic Bacterial Clinical Isolates From 2014 to 2016, Including Recently Named or Renamed Species.
    Byun JH; Kim M; Lee Y; Lee K; Chong Y
    Ann Lab Med; 2019 Mar; 39(2):190-199. PubMed ID: 30430782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is ciprofloxacin active against clinically important anaerobes?
    Watt B; Brown FV
    J Antimicrob Chemother; 1986 May; 17(5):605-13. PubMed ID: 2941400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of inoculum, pH, and medium on the activity of ciprofloxacin against anaerobic bacteria.
    Borobio MV; Perea EJ
    Antimicrob Agents Chemother; 1984 Mar; 25(3):342-3. PubMed ID: 6721466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms.
    Williams JD; Maskell JP; Shain H; Chrysos G; Sefton AM; Fraser HY; Hardie JM
    J Antimicrob Chemother; 1992 Jul; 30(1):27-37. PubMed ID: 1331019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobes.
    Goldstein EJ; Citron DM; Merriam CV; Warren Y; Tyrrell K
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2801-5. PubMed ID: 10543769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.